Trial
NCT02845336
Celecoxib for Thyroid Eye Disease
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Johns Hopkins University
Collaborators
—
Condition
Thyroid Eye Disease
Intervention
Celecoxib
Why stopped
Poor enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-31